Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery

References

• GowerEWLindsleyKNanjiAALeyngoldIMcDonnellPJPerioperative antibiotics for prevention of acute endophthalmitis after cataract surgeryCochrane Database Syst Rev20137CD00636423857416
   PubMed Web of Science ®Google Scholar
• SpeakerMGMilchFAShahMKEisnerWKreiswirthBNRole of external bacterial flora in the pathogenesis of acute postoperative endophthalmitisOphthalmology19919856396502062496
   PubMed Web of Science ®Google Scholar
• MahFSDavidsonRHollandEJASCRS Cornea Clinical CommitteeCurrent knowledge about and recommendations for ocular methicillin-resistant Staphylococcus aureusJ Cataract Refract Surg201440111894190825442885
   PubMed Web of Science ®Google Scholar
• HollandEJMcDonaldMBParekhJGSheppardJDAntibiotic resistance in acute postoperative endophthalmitisOphthalmology201412111 supplS1S925283879
   PubMed Web of Science ®Google Scholar
• BenzMSScottIUFlynnHWJrUnoniusNMillerDEndophthalmitis isolates and antibiotic sensitivities; a 6-year review of culture-proven casesAm J Ophthalmol20041371384214700642
   PubMed Web of Science ®Google Scholar
• GentileRCShuklaSShahMMicrobiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year reviewOphthalmology201412181634164224702755
   PubMed Web of Science ®Google Scholar
• YaoKZhuYZhuZThe incidence of postoperative endophthalmitis after cataract surgery in China: a multicenter investigation of 2006–2011Br J Ophthalmol201397101312131723884695
   PubMed Web of Science ®Google Scholar
• MollanSPGaoALockwoodADurraniOMButlerLPostcataract endophthalmitis: incidence and microbial isolates in a United Kingdom region from 1996 through 2004J Cataract Refract Surg200733226526817276268
   PubMed Web of Science ®Google Scholar
• KodjikianLSalvanet-BouccaraAGrillonSFrench Collaborative Study Group on EndophthalmitisPostcataract acute endophthalmitis in France: national prospective surveyJ Cataract Refract Surg2009351899719101430
   PubMed Web of Science ®Google Scholar
• OlsonRDonnenfeldEBucciFAJrMethicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgeryClin Ophthalmol201041505151421191448
   PubMedGoogle Scholar
• HsuHYLindJTTsengLMillerDOcular flora and their antibiotic resistance patterns in the Midwest: a prospective study of patients undergoing cataract surgeryAm J Ophthalmol2013155136.e44.e22995030
   PubMed Web of Science ®Google Scholar
• SutoCMorinagaMYagiTTsujiCToshidaHConjunctival sac bacterial flora isolated prior to cataract surgeryInfect Drug Resist20125374122294861
   PubMedGoogle Scholar
• Endophthalmitis Study GroupEuropean Society of Cataract and Refractive SurgeonsProphylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factorsJ Cataract Refract Surg200733697898817531690
   PubMed Web of Science ®Google Scholar
• DeCroosFCAfshariNAPerioperative antibiotics and anti- inflammatory agents in cataract surgeryCurr Opin Ophthalmol2008191222618090893
   PubMed Web of Science ®Google Scholar
• ChangDFBraga-MeleRMamalisNASCRS Cataract Clinical CommitteeProphylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member surveyJ Cataract Refract Surg200733101801180517889779
   PubMed Web of Science ®Google Scholar
• RudniskyCJWanDWeisEAntibiotic choice for the prophylaxis of post-cataract extraction endophthalmitisOphthalmology2014121483584124326107
   PubMed Web of Science ®Google Scholar
• ScoperSVReview of third- and fourth-generation fluoroquino-lones in ophthalmology: in vitro and in vivo efficacyAdv Ther2008251097999418836691
   PubMed Web of Science ®Google Scholar
• McDonaldMBlondeauJMEmerging antibiotic resistance in ocular infections and the role of fluoroquinolonesJ Cataract Refract Surg20103691588159820692574
   PubMed Web of Science ®Google Scholar
• SchimelAMMillerDFlynnHWEndophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven casesAm J Ophthalmol2013156150.e52.e23540710
   PubMed Web of Science ®Google Scholar
• BispoPJAlfonsoECFlynnHWMillerDEmerging 8-methoxyflu-oroquinolone resistance among methicillin-susceptible Staphylococcus epidermidis isolates recovered from patients with endophthalmitisJ Clin Microbiol20135192959296323824766
   PubMed Web of Science ®Google Scholar
• MeloGBBispoPJYuMCPignatariACHöfling-LimaALMicrobial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitisEye201125338238821336253
   PubMed Web of Science ®Google Scholar
• HaasWPillarCMZurenkoGELeeJCBrunnerLSMorrisTWBesifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteriaAntimicrob Agents Chemother20095383552356019506065
   PubMed Web of Science ®Google Scholar
• MillerDChangJSFlynnHWAlfonsoECComparative in vitro susceptibility of besifloxacin and seven comparators against ciprofloxacin-and methicillin-susceptible/nonsusceptible staphylococciJ Ocul Pharmacol Ther201329333934423289847
   PubMed Web of Science ®Google Scholar
• HaasWGearingerLSUsnerDWDecoryHHMorrisTWIntegrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profileClin Ophthalmol201151369137922034556
   PubMedGoogle Scholar
• HaasWGearingerLSHesjeCKSanfilippoCMMorrisTWMicrobiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacinAdv Ther201229544245522644963
   PubMed Web of Science ®Google Scholar
• HaasWPillarCMTorresMMorrisTWSahmDFMonitoring antibiotic resistance in ocular microorganisms: results from the ARMOR 2009 surveillance studyAm J Ophthalmol2011152456757421652021
   PubMed Web of Science ®Google Scholar
• CambauEMatratSPanXSTarget specificity of the new fluo-roquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coliJ Antimicrob Chemother200963344345019147516
   PubMed Web of Science ®Google Scholar
• MoshirfarMFeizVVitaleATWegelinJABasavanthappaSWolseyDHEndophthalmitis after uncomplicated cataract surgery with the use of fourth generation fluoroquinolones: a retrospective observational case seriesOphthalmology2007114468669117184840
   PubMed Web of Science ®Google Scholar
• JensenMKFiscellaRGMoshirfarMMooneyBThird and fourth-generation fluoroquinolones: retrospective comparison of endophthal-mitis after cataract surgery performed over 10 yearsJ Cataract Refract Surg20083491460146718721704
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards InstituteMethods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard-Eighth EditionWayne, PACLSI2009 CLSI document M07-A8
   Google Scholar
• Clinical and Laboratory Standards InstitutePerformance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational SupplementWayne, PACLSI2013 CLSI document M100-S23
   Google Scholar
• LeibowitzHMAntibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitisAm J Ophthalmol1991112suppl 429S33S1928271
   PubMedGoogle Scholar
• TaCNEgbertPRSinghKShriverEMBlumenkranzMSMiño De KasparHProspective randomized comparison of 3-day vs 1-hour preoperative prophylaxis for cataract surgeryOphthalmology2002109112036204112414411
   PubMed Web of Science ®Google Scholar
• SuzukiTTanakaHToriyamaKProspective clinical evaluation of 1.5% levofloxacin ophthalmic solution in ophthalmic perioperative disinfectionJ Ocul Pharmacol Ther2013291088789224180629
   PubMed Web of Science ®Google Scholar
• InoueYUsuiMOhashiYShiotaHYamazakiTPreoperative Disinfection Study GroupPreoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: a prospective randomized multicenter studyJap J Ophthalmol200852315116118661264
   PubMed Web of Science ®Google Scholar
• Snyder-PelmutterLSKatzHRMeliaMEffect of topical ciprofloxacin 0.3% and ofloxacin 0.3% on the reduction of bacterial flora on the human conjunctivaJ Cataract Refract Surg200026111620162511084269
   PubMed Web of Science ®Google Scholar
• MossJMNguyenDLiuYIComparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial floraOphthalmology2008115112013201618708260
   PubMed Web of Science ®Google Scholar
• HaasWPillarCMHesjeCKSanfilippoCMMorrisTWBactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzaeJ Antimicrob Chemother20106571441144720435780
   PubMed Web of Science ®Google Scholar
• HaasWPillarCMHesjeCKSanfilippoCMMorrisTWIn vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chlorideJ Antimicrob Chemother201166484084421393192
   PubMed Web of Science ®Google Scholar
• BowmanLMSiEPangJArchibaldRFriedlaenderMDevelopment of a topical polymeric mucoadhesive ocular delivery system for azithro-mycinJ Ocul Pharmacol Ther200925213313919284320
   PubMed Web of Science ®Google Scholar
• AkpekEKVittitowJVerhoevenRSOcular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulationJ Ocul Pharmacol Ther200925543343919857105
   PubMed Web of Science ®Google Scholar
• SiECBowmanLMHosseiniKPharmacokinetic comparisons of bromfenac in DuraSite and XibromJ Ocul Pharmacol Ther2011271616621332395
   PubMed Web of Science ®Google Scholar
• ShafieeABowmanLMHouEHosseiniKAqueous humor penetration of ketorolac formulated in DuraSite or DuraSite 2 delivery systems compared to Acular LS in rabbitsJ Ocul Pharmacol Ther201329981281623992042
   PubMed Web of Science ®Google Scholar
• ShafieeABowmanLMHouEHosseiniKOcular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyesClin Ophthalmol201371549155623940414
   PubMedGoogle Scholar
• MillerDFlynnPMScottIUAlfonsoECFlynnHWJrIn vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolatesArch Ophthalmol2006124447948316606872
   PubMedGoogle Scholar
• DeramoVALaiJCFastenbergDMUdellIJAcute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacinAm J Ophthalmol2006142572172516989762
   PubMed Web of Science ®Google Scholar
• DeramoVALaiJCWinokurJLuchsJUdellIJVisual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitisAm J Ophthalmol2008145341341718191097
   PubMed Web of Science ®Google Scholar
• RecchiaFMBusbeeBGPearlmanRBCarvalho-RecchiaCAHoACChanging trends in the microbiologic aspects of post-cataract endophthalmitisArch Ophthalmol2005123334134615767476
   PubMedGoogle Scholar
• MajorJCJrEngelbertMFlynnHWJrMillerDSmiddyWEDavisJLStaphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomesAm J Ophthalmol2010149227828319926069
   PubMed Web of Science ®Google Scholar
• MalhotraRGiraJBerdyGJBrusattiRSafety and tolerance of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group investigator-masked studyClin Ophthalmol2012685586322701313
   PubMedGoogle Scholar
• ParekhJGNewsomTHNielsenSSafety of besifloxacin ophthalmic suspension 0.6% in cataract surgery patientsJ Cataract Refract Surg201238101864186722999608
   PubMed Web of Science ®Google Scholar
• MajmudarPAClinchTESafety of besifloxacin ophthalmic suspension 0.6% in cataract or LASIK surgery patientsCornea201433545746224637269
   PubMed Web of Science ®Google Scholar
• NielsenSAMcDonaldMBMajmudarPASafety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients. [corrigendum in Clin Ophthalmol. 2013;7:725]Clin Ophthalmol2013714915623355771
   PubMedGoogle Scholar
• DonnenfeldELaneSHollandEA prospective, contralateral eye, double-masked study of the effect of besifloxacin 0.6% and moxifloxacin 0.5% on corneal epithelial wound healing following photorefractive keratectomyPoster presented at: ASCRS Symposium on Cataract, IOL and Refractive SurgeryApril 2013San Francisco, CA
   Google Scholar
• BlondeauJMBorsosSHesjeCKAntimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureusJ Chemother200719214615117434822
   PubMed Web of Science ®Google Scholar